Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury

Takeru Shimizu1, Tara A Macey, Nidia Quillinan

  • 1Department of Anesthesiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, USA.

Insights

Androgen signaling and poly (ADP-ribose) polymerase-1 (PARP-1) activity are essential for male-specific TRPM2 ion channel-mediated brain injury after stroke. Inhibiting TRPM2 protects males, but only when androgens and PARP-1 are active.

Area of Science:

  • Neuroscience
  • Ion Channel Physiology
  • Endocrinology

Background:

  • Transient receptor potential M2 (TRPM2) ion channels play a sexually dimorphic role in ischemic brain injury.
  • Androgen signaling and poly (ADP-ribose) polymerase-1 (PARP-1) are potential mediators of this male-specific pathway.

Purpose of the Study:

  • To investigate the role of androgen signaling in male-specific TRPM2-mediated neuronal death.
  • To determine if differential PARP-1 activation underlies male-specific TRPM2 channel activation and injury.

Main Methods:

  • Administration of TRPM2 inhibitor clotrimazole (CTZ) in male mice with varying androgen levels (intact, castrated, androgen-replaced).
  • Assessment of ischemic brain injury in male poly (ADP-ribose) polymerase-1 (PARP-1) knockout mice compared to wild-type (WT) mice.
  • Measurement of PARP activity in the peri-infarct region of male and female mice after ischemia.

Main Results:

  • TRPM2 inhibition by CTZ reduced infarct volume in male mice, an effect abolished by castration and restored by androgen replacement.
  • Male PARP-1 knockout mice exhibited reduced ischemic damage, and CTZ failed to protect them.
  • Ischemia elevated PARP activity more in males than females, with this difference disappearing after castration.

Conclusions:

  • TRPM2-mediated neuronal death in the male brain following ischemia is dependent on intact androgen signaling.
  • PARP-1 activity is crucial for male-specific TRPM2 channel activation and subsequent neuronal injury during stroke.